Ran L - Search Results

1

Hypoxia-Inducible Factor 1α Regulates the Transforming Growth Factor β1/SMAD Family Member 3 Pathway to Promote Breast Cancer Progression.

Peng J, Wang X, Ran L, Song J, Luo R, Wang Y. Peng J, et al. Among authors: ran l. J Breast Cancer. 2018 Sep;21(3):259-266. doi: 10.4048/jbc.2018.21.e42. Epub 2018 Sep 20. J Breast Cancer. 2018. PMID: 30275854 Free PMC article.

2

HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.

Tan JX, Wang XY, Li HY, Su XL, Wang L, Ran L, Zheng K, Ren GS. Tan JX, et al. Among authors: ran l. Int J Cancer. 2011 Mar 15;128(6):1303-15. doi: 10.1002/ijc.25460. Int J Cancer. 2011. PMID: 20473947

3

Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population.

Wu YT, Luo QQ, Li X, Arshad B, Xu Z, Ran L, Zhao CX, Wu H, Shi YL, Chen HR, Li H, Li HY, Wu KN, Kong LQ. Wu YT, et al. Among authors: ran l. J Cancer. 2018 Jan 1;9(3):548-555. doi: 10.7150/jca.22968. eCollection 2018. J Cancer. 2018. PMID: 29483960 Free PMC article.

4

Inhibition of Notch signaling pathway enhanced the radiosensitivity of breast cancer cells.

Peng JH, Wang XL, Ran L, Song JL, Zhang ZT, Liu X, Li HY. Peng JH, et al. Among authors: ran l. J Cell Biochem. 2018 Nov;119(10):8398-8409. doi: 10.1002/jcb.27036. Epub 2018 Jun 15. J Cell Biochem. 2018. Retraction in: J Cell Biochem. 2021 Nov;122 Suppl 1:S108. doi: 10.1002/jcb.30088 PMID: 29904942 Retracted.

5

Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma.

Peng JH, Zhang X, Song JL, Ran L, Luo R, Li HY, Wang YH. Peng JH, et al. Among authors: ran l. Medicine (Baltimore). 2019 Jan;98(2):e13554. doi: 10.1097/MD.0000000000013554. Medicine (Baltimore). 2019. PMID: 30633152 Free PMC article.

6

[Effect of silencing of hyaluronidase gene HYAL1 by RNA interference on proliferation of human breast cancer cells].

Tan JX, Ren GS, Tu G, Li XT, Wang XY, Ran L. Tan JX, et al. Among authors: ran l. Ai Zheng. 2006 Jul;25(7):844-8. Ai Zheng. 2006. PMID: 16831275 Chinese.

7

Cross-sectional study of hepatitis B virus infection in female breast cancer patients in China for the first time diagnosed.

Li ZX, Huang J, Hu L, Jiang ZY, Ran L, Liang XY, She RL, Ma CY, Feng JH, Song JY, Qu XQ, Peng BQ, Wu KN, Kong LQ. Li ZX, et al. Among authors: ran l. Clin Transl Oncol. 2025 Jan;27(1):257-264. doi: 10.1007/s12094-024-03578-2. Epub 2024 Jul 3. Clin Transl Oncol. 2025. PMID: 38958900

8

REG gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell.

Wang X, Tu S, Tan J, Tian T, Ran L, Rodier JF, Ren G. Wang X, et al. Among authors: ran l. Med Oncol. 2011 Mar;28(1):31-41. doi: 10.1007/s12032-010-9546-8. Epub 2010 May 14. Med Oncol. 2011. PMID: 20467919

9

On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test.

Lu LJ, Wang RJ, Ran L, Gan L, Bai Y, Jin LB, Yao ZX, Liu SC, Ren GS, Wu KN, Li HY, Kong LQ. Lu LJ, et al. Among authors: ran l. PLoS One. 2014 Apr 1;9(4):e93630. doi: 10.1371/journal.pone.0093630. eCollection 2014. PLoS One. 2014. PMID: 24690937 Free PMC article.

10

On the status of β-cell dysfunction and insulin resistance of breast cancer patient without history of diabetes after systemic treatment.

Lu LJ, Gan L, Hu JB, Ran L, Cheng QF, Wang RJ, Jin LB, Ren GS, Li HY, Wu KN, Kong LQ. Lu LJ, et al. Among authors: ran l. Med Oncol. 2014 May;31(5):956. doi: 10.1007/s12032-014-0956-x. Epub 2014 Apr 12. Med Oncol. 2014. PMID: 24729160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

893 results

Search Page

Filters